Stockscreener 앱 받기
28.04
4.98%
1.33
전일 마감가:
$26.71
열려 있는:
$27.55
하루 거래량:
804.36K
Relative Volume:
0.89
시가총액:
$1.71B
수익:
-
순이익/손실:
$-197.68M
주가수익비율:
-7.4574
EPS:
-3.76
순현금흐름:
$-158.88M
1주 성능:
+5.02%
1개월 성능:
-1.99%
6개월 성능:
+402.51%
1년 성능:
+247.89%
1일 변동 폭
$27.29
$29.49
1주일 범위
$25.93
$29.49
52주 변동 폭
$1.92
$31.18
Kodiak Sciences Inc Stock (KOD) Company Profile
명칭
Kodiak Sciences Inc
전화
650-281-0850
주소
1250 PAGE MILL RD, PALO ALTO, CA
KOD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
28.04 | 1.63B | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.35 | 117.00B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 78.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
827.02 | 50.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
370.00 | 48.28B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.81 | 37.81B | 4.98B | 69.59M | 525.67M | 0.5197 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 개시 | Jefferies | Buy |
| 2025-08-14 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2023-12-11 | 재개 | Goldman | Sell |
| 2023-11-17 | 업그레이드 | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-24 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-15 | 개시 | CapitalOne | Overweight |
| 2022-08-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-02-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 개시 | Evercore ISI | Outperform |
| 2021-03-01 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-02-17 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-01-25 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-11-30 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-11-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-03 | 개시 | Goldman | Buy |
| 2020-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 개시 | SunTrust | Buy |
| 2020-01-08 | 개시 | ROTH Capital | Buy |
| 2020-01-03 | 개시 | Jefferies | Buy |
| 2019-12-24 | 개시 | JP Morgan | Overweight |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-20 | 개시 | Chardan Capital Markets | Buy |
| 2018-10-29 | 개시 | Barclays | Overweight |
| 2018-10-29 | 개시 | BofA/Merrill | Buy |
| 2018-10-29 | 개시 | Morgan Stanley | Overweight |
모두보기
Kodiak Sciences Inc 주식(KOD)의 최신 뉴스
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright By Investing.com - Investing.com Nigeria
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright - Investing.com Nigeria
KOD: Analyst Raises Price Target to $38 with Buy Rating | KOD St - GuruFocus
Kodiak Sciences Is Riding A 325% Run Into Big Retina Readouts - Finimize
Aug Weekly: Is Kodiak Sciences Inc exposed to currency risksStop Loss & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Why Kodiak Sciences Inc. stock is in analyst buy zoneMarket Performance Report & Technical Analysis for Trade Confirmation - bollywoodhelpline.com
Chart Watch: Can Kodiak Sciences Inc lead its sector in growthJuly 2025 Technicals & Entry Point Confirmation Alerts - baoquankhu1.vn
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Update - MarketBeat
First Week of December 18th Options Trading For Kodiak Sciences (KOD) - Nasdaq
Kodiak Sciences (KOD) Price Target Increased by 24.19% to 28.05 - Nasdaq
Is Kodiak Sciences Inc. (K27) stock included in top ETFsStock Screening Results & Exceptional Growth Portfolio - bollywoodhelpline.com
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.7%Here's What Happened - MarketBeat
Hedge Fund Bets: Will Kodiak Sciences Inc benefit from seasonalityRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? - Yahoo Finance
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Kodiak Sciences (KOD) price target increased by 19.36% to 21.71 - MSN
How analysts rate Kodiak Sciences Inc. stock todayQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - ulpravda.ru
Kodiak Sciences (NASDAQ:KOD) Rating Increased to Strong-Buy at UBS Group - MarketBeat
Is Kodiak Sciences Inc. (K27) stock inflation resilient2025 Stock Rankings & Momentum Based Trading Signals - Улправда
Will Kodiak Sciences Inc. stock outperform value stocksTake Profit & Accurate Entry/Exit Alerts - ulpravda.ru
Is Kodiak Sciences (KOD) Pricing Reflect Recent Biotech Pipeline And Funding Developments Accurately - Sahm
Is Kodiak Sciences Inc. stock safe for conservative investorsWatch List & AI Powered Trade Plan Recommendations - Улправда
Can Kodiak Sciences Inc. stock weather global recessionJuly 2025 Institutional & Fast Moving Stock Trade Plans - Улправда
Is Kodiak Sciences Inc. (K27) stock ideal for retirement investors2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - MEXC
Retina biotech Kodiak Sciences to present at major J.P. Morgan event - Stock Titan
UBS Initiates Coverage of Kodiak Sciences (KOD) with Buy Recommendation - Nasdaq
KOD: UBS Initiates Coverage with 'Buy' Rating and $50 Price Targ - GuruFocus
UBS initiates Kodiak Sciences stock with Buy rating, $50 price target By Investing.com - Investing.com South Africa
UBS initiates Kodiak Sciences stock with Buy rating, $50 price target - Investing.com Australia
PRN_FinancialWrapper | PR NewswireKodiak Sciences IncCommon Stock (Nasdaq:KOD) Detailed Stock Data - FinancialContent
Kodiak Sciences launches public offering of 6 mln shares - MSN
Volume Recap: Why GeneDx Holdings Corp Equity Warrant stock is rated strong buy - moha.gov.vn
Will Kodiak Sciences Inc stock outperform value stocksProfit Target & Long Hold Capital Preservation Plans - moha.gov.vn
Is Kodiak Sciences Inc a good long term investmentInsider Selling Patterns & Low Entry Investment Ideas - Early Times
Kodiak Sciences Inc Stock Analysis and ForecastPrice Action Trading & Exceptional Capital Investment - earlytimes.in
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.8%Here's Why - MarketBeat
The Biggest IPO of the Year Prompts Huge Insider Buy - AOL.com
Investors Buy Big as Medline’s IPO Raises Over $6 Billion - cointurk finance
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.8%Here's Why - MarketBeat
Kodiak Sciences stock hits 52-week high at $29.52 By Investing.com - Investing.com Australia
Kodiak Sciences Stock Surge: An In-Depth Look - timothysykes.com
Kodiak Sciences (NASDAQ:KOD) Shares Up 6%Here's Why - MarketBeat
Kodiak Sciences stock hits 52-week high at $29.52 - Investing.com
Kodiak Sciences (NASDAQ:KOD) Hits New 52-Week HighWhat's Next? - MarketBeat
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 - Finviz
Kodiak Sciences (NASDAQ:KOD) Shares Gap Up After Insider Buying Activity - MarketBeat
Kodiak Sciences Inc (KOD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.46%
0.83%
자본화:
|
볼륨(24시간):